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The adult human liver hosts a complex repertoire of liver resident and transient natural
killer (NK) cell populations with diverse phenotypes and functions. Liver resident NK cells
are CD56bright NK cells defined by a unique expression profile of transcription factors and
cell surface markers (EomeshiTbetloTIGIT+CD69+CXCR6+CD49e−). Despite extensive
characterization of the phenotype of liver resident NK cells, it remains unclear how
factors within the liver microenvironment induce and maintain this unique phenotype.
In this study, we have explored the factors regulating the phenotype of liver resident NK
cells. Isolation of healthy liver resident NK cells from donor liver perfusate and in vitro
culture results in the gradual loss of the characteristic Tbetlo phenotype, with the cells
increasing Tbet expression significantly at day 7. This phenotypic loss could be halted
through the dose-dependent addition of liver conditioned media (LCM), generated from
the ex vivo culture of liver biopsies from healthy organ donors. TGF-β, but not IL-10,
replicated the Tbet suppressive effects of LCM in both liver resident and peripheral blood
NK cells. Furthermore, blocking TGF-β receptor signaling using the inhibitor SB431542,
reversed the effect of LCM treatment on liver resident NK cells, causing the loss of
tissue resident Eomeshi Tbetlo phenotype. Our findings identify liver-derived TGF-β as an
important component of the liver microenvironment, which acts to regulate and maintain
the phenotype of liver resident NK cells.
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INTRODUCTION
Large populations of tissue resident natural killer (NK) cells have been identified in a diverse range
of tissues including liver, lung, lymph node, bone marrow, and uterus (1). However, the tissue-
specific factors regulating resident NK cell phenotype and function remain largely unknown. The
adult human liver hosts a diverse repertoire of liver resident and transient NK cell populations
with differing phenotypes and functions, whose roles in liver homeostasis and disease remain
poorly defined.
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Liver resident NK cells are enriched in the CD56bright NK cell
subpopulation and are defined by their unique expression of the
transcription factors Eomes and Tbet, and a range of cell surface
markers including TIGIT, CD69, CXCR6, and the absence of
CD49e (EomeshiTbetloHobit+TIGIT+CD69+CXCR6+CD49e−)
(2–6). This liver resident phenotype is absent in peripheral
blood NK cell populations. Expression of the chemokine receptor
CXCR6 is thought to be particularly important for the retention
of resident populations within the liver due to constitutive
expression of the ligand (CXCL16) in the liver sinusoid.
Despite extensive characterization of the phenotype of liver
NK cells, it remains unclear how factors within the liver
microenvironment contribute to the induction and maintenance
of this unique phenotype. Our group has previously described
the wide range of cytokines and growth factors present in
healthy adult liver which can maintain and propagate NK
cells (7–10). However, this work did not explore specific liver
resident NK cell phenotypes. Previous research identified that
liver resident NK cells produce significantly less IFN-γ compared
with corresponding peripheral blood NK cell populations, and
liver conditioned media (LCM) was sufficient to suppress
IFN-γ in peripheral blood CD56bright cells (2, 3), suggesting
that liver-derived soluble factors are capable of regulating NK
cell populations.
In this study we demonstrate that LCM can maintain the liver
resident NK cell phenotype ex vivo, as well as suppress Tbet and
Eomes expression in peripheral NK cells (which mirrors the Tbet
phenotype observed in liver resident NK cells). Furthermore,
we show TGF-β, produced in the liver microenvironment,
suppresses Tbet and Eomes expression in liver resident NK cells
and peripheral blood NK cells. Understanding how the liver
microenvironment induces and maintains liver specific immune
cell populations may identify novel therapeutic targets capable of
regulating local immunity and tissue repair.
MATERIALS AND METHODS
Collection of Liver Perfusate During
Orthotopic Liver Transplantation (OLT)
Samples were collected from donor livers (n = 10) during
orthotopic liver transplantation at St. Vincent’s University
Hospital. During retrieval, the donor aorta and superior
mesenteric vein were flushed with University of Wisconsin
(UW) solution (Bristol-Myers Squibb, Uxbridge, UK) at the
time of exsanguination. The liver was flushed again with UW
solution after excision of the organ until all blood was removed
and the perfusate appeared clear, at which time the liver was
placed in a container with UW solution and packed on ice
for transportation. Donor livers were transplanted within 12 h.
At implantation, after completion of the upper inferior cava
anastomosis, livers were flushed with normal saline through
the portal vein to wash out the UW before reperfusion. This
wash-out fluid was collected from the inferior vena cava; the
UW transportation solution was also collected. A matched
donor blood sample was taken at the time of organ retrieval.
Peripheral blood was obtained from anonymised blood donors
from the Irish Blood transfusion Board (IBTS). All protocols were
approved by St. Vincent’s University Hospital Ethics Committee
and the Trinity College Dublin School of Medicine Research
Ethics Committee, in accordance with the ethical guidelines of
the 1975 Declaration of Helsinki.
Isolation of Hepatic Mononuclear Cells
From Liver Perfusate and Peripheral Blood
Hepatic mononuclear cells (HMNCs) were isolated from donor
liver perfusates, as previously described (11), by filtration
through 70µm filters (BD Biosciences, Erembodegem, Belgium)
followed by centrifugation at 1,200 rpm for 10min. The
supernatant was aspirated and the cells resuspended in RPMI
1640 medium, supplemented with 10% fetal calf serum and 1%
penicillin/streptomycin (Gibco,Wicklow, Ireland). HMNCswere
separated from this suspension by density gradient centrifugation
using Ficoll-PaqueTM PLUS (GE Healthcare, Uppsala, Sweden)
and residual red blood cells were removed by adding red cell
lysis solution (Sigma, Wicklow, Ireland). Matched peripheral
blood mononuclear cells (PBMCs) were also isolated by
density centrifugation.
Preparation of Liver Conditioned Media
Wedge biopsies, taken at the time of transplantation, were
used to generate tissue conditioned media. Tissue samples
were measured and weighed. Tissue was then cut into sections
measuring approximately 0.5 cm × 0.5 cm × 0.5 cm. These
were placed in a 24-well-culture plate and 500 µl of X-VIVO
(Lonza Biologics, Slough, UK) media was added to each well and
incubated for 72 h at 37◦C. Following incubation, the supernatant
was centrifuged to remove cell debris and stored at −20◦C
until use.
Isolation of NK Cells From Liver Perfusate
and Peripheral Blood
CD3−CD56+ NK cells were isolated from fresh liver perfusates
and healthy donor peripheral blood by negative selection using
NK cell isolation kits (130-092-657; Miltenyi Biotech, Teterow,
Germany, and 480054; BioLegend, CA, USA), as per the
manufacturers protocol. Briefly, mononuclear cells were labeled
with a biotin conjugated antibody cocktail against lineage specific
targets. Anti-biotin microbeads were then added, and the NK
cells were separated using a magnetic cell sorting (MACS) LS
column. Cells were then cultured in RPMI 1640 supplemented
with 10% fetal calf serum and 1% penicillin/streptomycin. In
addition, NK cells were sorted into two populations CD56bright
CD16+/− and CD56dim CD16++ using a FACS Aria cell sorter
(BD Biosciences).
Culture of Hepatic and Peripheral Blood
NK Cells
Isolated NK cells were plated at 5 × 105/ml in round-bottomed
96 well-plates in RPMI 1640 supplemented with 10% Human
AB serum and rhIL-15 (2 ng/ml) for 7 days in the presence or
absence of liver conditionedmedia (5/10% v/v), TGF-β (5 ng/ml),
or IL-10 (10 ng/ml). Media was changed every 2–3 days.
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Phenotypic Analysis of NK Cells
HMNCs, PBMCs and cultured NK cells were stained with
fluorescently labeled monoclonal antibodies to determine the
phenotypic differences between hepatic and peripheral NK cells.
The following antibodies were used: CD45 (HI30) BV510, CD3
(UCHT1) BV421 or Pacific Blue, CD56 (NCAM16.2) BV650
or APC, CD16 (3G8) PE-Cy7, CXCR6 PE-CF594. Intracellular
staining was performed using FoxP3 staining buffer (00-5523-00,
eBiosciences, San Diego, CA, USA) and the following antibodies
were used: Eomes (WD1928) AF488 and T-bet (ebio4B10) PE
(BioLegend). Dead cell exclusion was carried out using fixable
viability stain 780 (BD Biosciences). Flow cytometric analysis was
carried out using an LSR Fortessa (BD Biosciences) or a FACS
Canto II (BD Biosciences) and data was analyzed using FlowJo
(Version 7.6.5, Tree Star, Ashland, OR, USA).
Statistical Analysis
Statistical analysis was carried out using PrismGraphPadVersion
5.0. For comparison of two unmatched groups, Mann Whitney
U-test was used. Comparison of more than two unmatched
groups was performed using Kruskal-Wallis test, with Dunn’s
multiple comparison test. For paired comparisons, Friedman test
with Dunns multiple comparison tests was used for more than
two groups, Wilcoxon signed rank test was used for comparison
of two matched groups. Within an experiment, ∗p < 0.05,
∗∗p < 0.01, and ∗∗∗p < 0.001, respectively.
RESULTS
Liver Resident NK Cells Are Characterized
by a EomeshiTbetloCXCR6+ Phenotype,
Which Is Gradually Lost Upon ex vivo
Culture
NK cells from donor liver perfusate and matched peripheral
blood were analyzed for expression of Eomes, Tbet, and CXCR6.
As previously described, CD56bright NK cells from liver perfusate
displayed reduced expression of Tbet (LP: MFI 554 ± 69.6,
PB: MFI 1074 ± 189.9, p = 0.0024, Figures 1A,B). Liver
CD56bright NK cells had increased expression of Eomes compared
to matched blood cells (LP: MFI 2092 ± 337, PB: MFI 1126
± 248, p = 0.0005, Figure 1C). Liver CD56bright cells also
express CXCR6, which is almost undetectable on peripheral
blood counterparts (LP: 52.1± 10.1%, PB: 3.1± 1.9%, p= 0.0223,
Figure 1D). In contrast, CD56dim NK cells from liver perfusate
resemble their peripheral blood counterparts with no significant
differences in Eomes, Tbet, or CXCR6 (Figures 1E–G).
In order to determine whether the phenotype of hepatic
NK cells is permanently altered by residing within the liver
microenvironment, NK cells were isolated from liver perfusate
and cultured in RPMI supplemented with human AB serum,
to replicate the peripheral blood microenvironment. It was
necessary to supplement this culture with IL-15 (2 ng/ml) in
order to maintain NK cell viability and expression of CD56
(12, 13). NK cells were cultured for 7 days with the culture media
replaced every 2–3 days.
Upon ex vivo culture the unique phenotype of CD56bright
hepatic NK cells is lost, with Tbet increasing significantly between
day 0 (MFI 461.5± 255.5) and day 7 (MFI 1214± 572, p= 0.042,
Figures 2A,B). Eomes expression increased but this did not reach
statistical significance (day 0 MFI 2147 ± 632 and day 7 MFI
3497 ± 1500, p = 0.3, Figure 2C). Expression of the chemokine
receptor, CXCR6, showed a trend toward decreasing on hepatic
CD56bright NK cells upon ex vivo culture, however this did not
reach statistical significance (day 0, 71.8± 10.2%, and day 7, 40.3
± 10.4%; p= 0.052, Figure 2D).
In CD56dim hepatic NK cells, Tbet remained stable during
culture with the MFI ranging between MFI 2007 at day 0 and
MFI 1550 at day 7 (p = 0.69, Figure 2E). Eomes expression
increased between day 0 (MFI 1463 ± 516) and day 7 (MFI
3364 ± 1807, Figure 2F) but this did not reach statistical
significance. CXCR6 expression in CD56dim hepatic NK cells
increased marginally, however this increase was not statistically
significant and even at day 7 only represents a small minority of
the total CD56dim population (Day 0 2.5 ± 1.3% vs. day 7 6.6 ±
2.4%; p= 0.3, Figure 2G).
The Eomeshi Tbetlo Phenotype of Liver
Resident NK Cells Can be Maintained ex
vivo by Supplementing With Liver
Conditioned Media
Hepatic CD56bright NK cells have a unique pattern of Eomes and
Tbet expression, which is lost upon long term culture. In order
to determine the effect of the liver microenvironment on these
transcription factors, we assessed Eomes and Tbet expression
after ex vivo culture supplemented with LCM (n = 5). LCM
significantly reduced the expression of Tbet in liver resident NK
cells, in a dose dependent manner, to a level similar to that seen
at day 0. At day 7, the MFI of Tbet in untreated CD56bright NK
cells was 724.3 ± 170.4 MFI, rising from 323.7 ± 34.3 MFI at
day 0. This was reduced to 391.0 ± 29.8 MFI with 5% LCM
and further reduced to 261.7 ± 11.9 with 10% LCM (p = 0.017,
Figures 3A,B). Similarly, the increase in Eomes expression upon
ex vivo culture of CD56bright NK cells was significantly reduced
by treatment with LCM in a dose dependent manner. By day
7, Eomes MFI in untreated NK cells had risen to 3,149 ± 389.9
from 1,343 ± 204.4 at day 0. Treatment with 5% LCM reduced
the MFI to 1,774 ± 630.6, with a further reduction to 983.3 ±
243.1 MFI with 10% LCM (p = 0.0278, Figure 3C). At day 7,
CXCR6 was expressed on 45.5 ± 6.4% of CD56bright NK cells.
This level increased to 58.0± 15.5% and 65.3± 10.8% with 5 and
10% LCM, respectively (p= 0.21, Figure 3D).
Hepatic CD56dim NK cells behave in a similar manner when
treated with LCM although the effect is not as pronounced as
in CD56bright NK cells. Tbet expression is reduced in a dose
dependent manner (untreated MFI 789.7 ± 171.8, 5% LCM
MFI 720.7 ± 19.7, 10% LCM MFI 553.2 ± 7.8, p = 0.18,
Figure 3E). A dose dependent decrease in Eomes expression was
also seen, returning the MFI of Eomes to levels seen at day 0
(untreated MFI 2323 ± 4336, 5% LCM MFI 1157 ± 164.9, 10%
LCM MFI 736 ± 118, p = 0.0331, Figure 3F). No significant
change was seen in expression of CXCR6 on CD56dim NK cells
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FIGURE 1 | CD56bright NK cells have unique tissue resident phenotype. Mononuclear cells isolated from liver perfusate (LP) and matched peripheral blood (PB)
were stained with monoclonal antibodies. NK cells were identified from the CD45+ lymphocyte gate as CD56+CD3−. CD56brightCD16−/+ and CD56dimCD16+
subsets were then gated and non-viable cells were excluded by FVS780 staining. (A) Representative histograms of Tbet, Eomes and CXCR6 expression in LP and PB
NK cell subsets. (B) The MFI of Tbet in CD56bright NK cells. (C) The MFI of Eomes in CD56bright NK cells. (D) Percentage of CXCR6 positive CD56bright NK cells.
(E) The MFI of Tbet in CD56dim NK cells. (F) The MFI of Eomes in CD56dim NK cells. (G) Percentage of CXCR6 positive CD56dim NK cells. Data presented as mean
± SEM (D,G) or box and whisker plots with minimum and maximum values (B,C,E,F). Data was analyzed using Wilcoxon matched pairs test (n = 10; *p < 0.05,
**p < 0.01, and ***p < 0.001).
FIGURE 2 | Tbet expression increases in liver resident NK cells cultured ex vivo. NK cells isolated from liver perfusate (LP) were cultured for 7 days and stained with
monoclonal antibodies to assess transcription factor expression. (A) Representative histograms of Tbet, Eomes and CXCR6 expression from cells at day 0 (black line),
day 3 (blue line), day 5 (orange line), and day 7 (red line). (B) MFI of Tbet in CD56bright NK cells from LP at day 0, 3, 5, and 7. (C) MFI of Eomes CD56bright NK cells
from LP at day 0, 3, 5, and 7. (D) Percentage of CXCR6 positive CD56bright NK cells from LP at day 0, 3, 5, and 7. (E) MFI of Tbet in CD56dim NK cells from LP at
day 0, 3, 5, and 7. (F) MFI of Eomes in CD56dim NK cells from LP at day 0, 3, 5, and 7. (G) Percentage of CXCR6 positive CD56dim NK cells from LP at day 0, 3, 5,
and 7. Data presented as mean ± SEM (D,G) or box and whisker plots with minimum and maximum values (B,C,E,F). Data was analyzed using Friedman test, with
Dunn’s multiple comparison test (n = 5; *p < 0.05).
(untreated 6.6± 2.4%, 5% LCM 3.6± 2.1%, 10% LCM 4.1± 2.6,
p= 0.72, Figure 3G).
Treatment of Peripheral Blood NK Cells
With LCM Suppresses Tbet and Eomes
Expression but Fails to Induce CXCR6
Expression
In contrast to hepatic NK cells, blood CD56bright NK cells do
not significantly increase their expression of Tbet in culture (Day
0 954.7 ± 47.5 MFI, Day 7 973.5 ± 88.5 MFI, Figures 4A,B).
However, treatment with LCM induces reduced Tbet expression
after 7 days of treatment (Day 0 954.7 ± 47.5 MFI, Day 7 5%
LCM 443 ± 91.2, 10% LCM 395.3 ± 25.2 MFI, p = 0.033,
Figure 4B). At day 0 the MFI of Eomes was 1,514 ± 237.1 for
CD56bright cells, by day 7 the MFI had increased to 2,371 ± 267
(Figure 4C). This was reduced by addition of LCM to 1,177± 209
MFI (5% LCM) and 927.7 ± 34.2 MFI (10% LCM). Peripheral
blood CD56bright NK cells do not basally express CXCR6 and
the receptor was not upregulated at any point during the
experiment (Figure 4D).
CD56dim NK cells also undergo a significant decrease in
Tbet expression after LCM treatment (day 0 1198 ± 72.8
MFI, Day 7 untreated 1,012 ± 99.1 MFI, 5% LCM 418
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FIGURE 3 | Liver resident phenotype can be maintained by the addition of liver conditioned media. NK cells isolated from liver perfusate (LP) were cultured for 7 days,
supplemented with 5 or 10% v/v liver conditioned media (LCM) and stained with monoclonal antibodies to assess transcription factor expression. (A) Representative
histograms of Tbet, Eomes and CXCR6 expression from cells at day 0 (black line), day 7 untreated (blue line), day 7 5% LCM (orange line), and day 7 10% LCM (red
line). (B) MFI of Tbet CD56bright NK cells from LP at day 0 and 7 with LCM treatments. (C) MFI of Eomes in CD56bright NK cells from LP at day 0 and 7 with LCM
treatments. (D) Percentage of CXCR6 positive CD56bright NK cells from LP at day 0 and 7 with LCM treatments. (E) MFI of Tbet in CD56dim NK cells from LP at day 0
and 7 with LCM treatments. (F) MFI of Eomes in CD56dim NK cells from LP at day 0 and 7 with LCM treatments. (G) Percentage of CXCR6 positive CD56dim NK cells
from LP at day 0 and 7 with LCM treatments. Data presented as mean ± SEM. Data was analyzed using Friedman test, with Dunn’s multiple comparison test (n = 5;
*p < 0.05).
FIGURE 4 | Liver conditioned media suppresses Tbet expression in blood NK cells. NK cells isolated from peripheral blood (PB) were cultured for 7 days,
supplemented with 5 or 10% v/v liver conditioned media (LCM) and stained with monoclonal antibodies to assess transcription factor expression. (A) Representative
histograms of Tbet, Eomes and CXCR6 expression from cells at day 0 (black line), day 7 untreated (blue line), day 7 5% LCM (orange line), and day 7 10% LCM (red
line). (B) MFI of Tbet in CD56bright NK cells from PB at day 0 and 7 with LCM treatments. (C) MFI of Eomes in CD56bright NK cells from PB at day 0 and 7 with LCM
treatments. (D) Percentage of CXCR6 positive CD56bright NK cells from PB at day 0 and 7 with LCM treatments. (E) MFI of Tbet in CD56dim NK cells from PB at day
0 and 7 with LCM treatments. (F) MFI of Eomes in CD56dim NK cells from PB at day 0 and 7 with LCM treatments. (G) Percentage of CXCR6 positive CD56dim NK
cells from PB at day 0 and 7 with LCM treatments. Data presented as mean ± SEM. Data was analyzed using Friedman test, with Dunn’s multiple comparison test
(n = 5; *p < 0.05).
± 83.5 MFI, 10% LCM 464.7 ± 21.5 MFI, p = 0.017,
Figure 4E). At day 0 the MFI of Eomes was 1,500 ± 420.5
for CD56dim NK cells. At day 7 the MFI had increased
to 2,155 ± 163.5, this was reduced to basal levels with
the addition of LCM (5% LCM 1,040 ± 199.5 MFI, 10%
LCM 859.9 ± 41 MFI, Figure 4F). Expression of CXCR6 on
peripheral blood CD56dim NK cells was negligible at all time
points (Figure 4G).
TGF-β, Which Is Present in the Liver
Microenvironment, Is Capable of
Suppressing Tbet ex vivo in Liver Resident
and Blood NK Cells
We next attempted to identify the factor present in LCM
responsible for maintaining this liver resident phenotype. IL-
10 and TFG-β are two immunosuppressive cytokines which can
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FIGURE 5 | TGF-β can regulate Tbet expression in liver resident and blood NK cells. Liver conditioned media (LCM) was generated from healthy donor liver biopsies.
ELISA was performed for the cytokines TGF-β and IL-10. (A) Concentration of cytokines TGF-β and IL-10 from matched LCM samples (n = 10). CD56bright Eomeshi
Tbetlo NK cells FACS isolated from liver perfusate (LP) were cultured for 7 days, supplemented with 10% v/v liver conditioned media (LCM), IL-10 (10 ng/ml) or TGF-β
(5 ng/ml) and acquired on a FACS Fortessa. (B) Representative histogram of Tbet expression from cells at day 7 untreated (blue line), 10% LCM (orange line), IL-10
(red line), and TGF-β (green line). (C) MFI of Tbet in CD56bright NK cells from LP at day 7 with LCM, IL-10 or TGF-β treatments. (D) MFI of Eomes in CD56bright NK
cells from LP at day 7 with LCM, IL-10 or TGF-β treatments. (E) Representative histogram of Tbet expression from blood NK cells at day 7 untreated (blue line) or
TGF-β (green line). (F) MFI of Tbet in PB CD56bright NK cells at day 7 with or without TGF-β. (G) MFI of Eomes in PB CD56bright NK cells at day 7 with or without
TGF-β. Data presented as mean ± SEM (A) or box and whisker plots with minimum and maximum values (C,D,F,G). Data was analyzed using Friedman test, with
Dunn’s multiple comparison test or paired t-test (n = 5; *p < 0.05 and **p < 0.01).
suppress IFN-γ production in NK cells and T cells (14–16).
Our group has previously reported the presence of several NK
related cytokines, including the essential IL-15, activatory IL-
12 and IL-18, and regulatory IL-10 and TGF-β in healthy liver
tissue (9). Secreted TGF-β and IL-10 were detected in all LCM
samples at concentrations of 270.3 ± 63.1 pg/ml and 124.3 ±
22.3 pg/ml, respectively (Figure 5A). Next, we assessed the effect
of IL-10 and TGF-β on the phenotype on hepatic NK cells
in culture.
Hepatic CD56brightEomeshiTbetlo NK cells were isolated by
FACS sorting. They were cultured in RPMI supplemented with
10% human AB serum and IL-15 (2 ng/ml) for 7 days with or
without LCM (10% v/v), IL-10 (10 ng/ml), or TGF-β (5 ng/ml).
Media was replenished ever 2–3 days. As before Tbet and Eomes
expression increased during culture and LCM significantly
reduced the expression of Tbet and Eomes (Figures 5B–D). IL-10
had no effect on Tbet expression (MFI 792.4 ± 56.4, Figure 5C),
however TGF-β significantly reduced the expression of Tbet
compared to untreated cells (untreated MFI 760.5 ± 46.9, LCM
381.1± 78.2, TGF-β 385.2± 79.8, p= 0.0014, Figure 5C). IL-10
did not significantly alter the expression of Eomes, while TGF-β
reduced Eomes expression to a similar level to LCM, however this
did not reach statistical significance (Figure 5D).
Treatment of magnetic bead-purified peripheral blood NK
cells with TGF-β for 7 days likewise resulted in a significant
decrease in Tbet expression in CD56bright NK cells (Day 7
untreated 5,776 ± 679 MFI, TGF-β treated 2,979 ± 328 MFI,
p = 0.0421, Figures 5E,F). A significant decrease in Eomes
expression upon TGF-β treatment was also observed (Day
7 untreated 873 ± 34 MFI, TGF-β treated 539 ± 19 MFI,
p= 0.0024, Figure 5G).
Inhibiting TGF-β Signaling Partially
Reverses the Effect of LCM Treatment on
Liver Resident and Blood NK Cells
We next inhibited TGF-β receptor signaling using the inhibitor
SB431542, which inhibits the TGF-β type I receptor activin
receptor-like kinase (ALK)5 and related genes ALK4 and ALK7.
Liver CD56bright NK cells were pre-treated with SB431542 for
2 h before being treated with LCM. As before, treatment with
LCM significantly reduced the expression of Tbet compared to
untreated cells (Figures 6A,B). Pre-treatment with SB431542
prevented the reduction in Tbet expression (LCM: MFI 356
± 49.6, LCM+SB431542: MFI 552.8 ± 69.6, p = 0.0239,
Figure 6B). The addition of SB431542 also significantly
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FIGURE 6 | Blocking TGF-β inhibits the ability of liver conditioned media to suppress Tbet and Eomes expression. CD56bright Eomeshi Tbetlo NK cells FACS isolated
from liver perfusate (LP) were cultured for 7 days, supplemented with 10% v/v liver conditioned media (LCM) with and without SMAD inhibitor SB431542 and acquired
on a FACS Fortessa. (A) Representative histogram of Tbet expression from cells at day 7 untreated (blue line), 10% LCM (orange line) or LCM & SB431542 (red line).
(B) MFI of Tbet in CD56bright NK cells from LP at day 7 with LCM or LCM & SB431542. (C) MFI of Eomes in CD56bright NK cells from LP at day 7 with LCM or LCM &
SB431542. NK cells isolated from peripheral blood (PB) were cultured for 7 days, supplemented with 10% v/v LCM with 5µg/mL anti-TGF-β1 blocking antibody or
IgG isotype control and acquired on a FACS Canto II. (D) Representative histogram of Tbet expression in CD56bright NK cells from peripheral blood at day 7 with LCM
or LCM & TGF-β1 blocking antibody. (E) MFI of Tbet in CD56bright NK cells from peripheral blood at day 7 with LCM or LCM & TGF-β1 blocking antibody. (F) MFI of
Eomes in CD56bright NK cells from peripheral blood at day 7 with LCM or LCM & TGF-β1 blocking antibody. Data presented as mean ± SEM. Data was analyzed
using Friedman test, with Dunn’s multiple comparison test or repeated measures one-way ANOVA (n = 3–8, *p < 0.05 and **p < 0.01).
increased the expression of Eomes compared to LCM treated
cells (Figure 6C).
In order to confirm that this effect was specific to TGF-β
receptor signaling we next treated magnetic bead-purified blood
NK cells with LCM and 5µg/ml of a TGF-β1 blocking antibody
(clone 19D8, BioLegend) or isotype control (clone MOPC-21,
BioLegend). Blocking TGF-β1 prevented the inhibition of Tbet
in CD56bright NK cells (Figures 6D,E). Blocking TGF-β1 also
prevented the inhibition of Eomes by LCM although this did not
reach statistical significance (Figure 6F).
DISCUSSION
In this study, we have shown that the liver microenvironment is
essential for maintaining the unique EomeshiTbetlo phenotype
of liver resident NK cells. NK cells isolated from liver perfusate
lose their unique EomeshiTbetlo phenotype when cultured, but
this can be reversed by the addition of LCM. The liver is rich
in immunoregulatory cytokines, including TGF-β and IL-10,
produced by Kupffer cells and immature dendritic cells (9, 17–
19). Liver resident NK cells cultured with TGF-β, but not IL-10,
maintain their EomeshiTbetlo phenotype, indicating that TGF–β
is essential for maintaining liver resident populations. Blocking
TGF-β signaling through pre-treatment with SB431542 reverses
this effect and shifts the phenotype of liver resident NK cells to
a peripheral blood-like state. Furthermore, Tbet expression in
peripheral blood NK cells can be modulated by treatment with
both LCM and TGF–β.
Culture with LCM can maintain CXCR6 expression, but
it does not appear to induce expression of CXCR6 on
peripheral blood NK cells. Cytokine stimulation (IL-12, IL-
15) of peripheral blood NK cells can induce CXCR6 or
CD49a expression, however the level of CXCR6 expression was
highly variable and less than half of the stimulated NK cells
showed expression, suggesting additional stimuli are required
for sustained CXCR6 expression (20). NK cells may acquire
CXCR6 expression in the periphery, through cytokine activation,
and migrate to the liver. Here CXCL16, RANTES, and CCL3,
present in the liver sinusoid, may retain activated NK cells
(4, 21) and possibly sustain CXCR6 expression. Following
recruitment to the liver sinusoid, TGF-β (produced by resident
macrophages and dendritic cells) may alter transcription factor
expression and repress the production of pro-inflammatory
cytokines (IFN-γ).
Significant work has been performed investigating the effect
of TGF-β on NK cells. TGF-β has been shown to have potent
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immunosuppressive effects and alters NK cell development
(15, 22). Furthermore, TGF-β has been shown to suppress
glycolysis and inhibit the pro-inflammatory effector functions
of CD56bright NK cells, such as IFN–γ production (23). The
mechanism by which TGF-β inhibits Tbet and IFN-γ has
previously been elucidated in T cells, where TGF-β signaling
induces the expression of SHP-1 which in turn inhibits STAT1/4
and Tbet expression (24, 25). Recently, TGF-β has been shown
to be involved in the conversion of NK cells to ILC1-like cells,
via a JNK-dependent, Smad4-independent pathway resulting
in reduced cytotoxicity in murine tumor models (26, 27).
Why this process does not appear to occur in liver resident
NK cells warrants further investigation. Intriguingly, Smad4
appears to suppress the JNK-dependent non-canonical TGF-
β signaling associated with differentiation into ILC1-like cells
within tissues, indicating that canonical TGF-β signals may
be required to maintain NK cell phenotype. It is important
to note there is a marked differences in the phenotype and
function of liver resident NK cells between humans and mice
(28). Furthermore, single cell RNA-seq analysis of human
and murine NK cells have highlighted similarities but also
significant differences in peripheral blood and splenic samples
(29). Therefore, TGF-β may have divergent functions between
species and care must be taken when comparing murine and
human data.
In this study, we identified TGF-β as a factor required for the
induction and maintenance of the tissue resident phenotype of
liver resident NK cells in humans. Liver resident NK cells are
unique in that they can provide immunosurveillance without
producing large quantities of IFN-γ with its potential to drive
tissue damaging pathology. In this context, liver resident NK cells
can remove dysplastic or virally infected cells without perturbing
the tolerogenic milieu of the liver, which so often leads to chronic
inflammatory conditions. Further evidence for the importance of
TGF-β in the establishment and maintenance of tissue resident
NK cell populations in humans comes from analysis of uterine
NK cells. Uterine NK cells share many phenotypic characteristics
with liver resident NK cells (CD56brightEomeshiCD69+) (30).
The local uterine microenvironment is rich in TGF-β and
treatment of blood NK cells with either endometrial stromal cell
supernatants or TGF-β alone can induce phenotypic changes
resembling decidual NK cells (31).
Our results suggest that disruption of TGF–β levels in the
liver microenvironment in disease could lead to a loss of local
immune regulation and the promotion of tissue inflammation
and damage. While the roles of liver resident NK cells in
maintaining homeostasis or mediating liver disease have yet to
be established in humans, a reduction in TGF-β levels during
liver disease could drive resident NK cell populations to a more
conventional pro-inflammatory phenotype and contribute to
chronic inflammation. In this situation, restoring homeostatic
cytokine levels would be essential to regulate local immunity
and tissue repair in the liver. Interestingly, the use of a strong
pro-inflammatory signal, such as PMA, appears to overcome
this TGF-β mediated repression and restore IFN-γ production
(2, 5). This appears similar to the mechanism by which TGF-β
imprinted peripheral blood NK cells become hyper-producers of
IFN-γ in vitro (32). While in healthy liver these resident NK cells
have suppressed pro-inflammatory function, it appears this can
be overcome with sufficient stimulation.
The liver is a naturally tolerogenic environment, which
maintains unique anti-inflammatory status even in the presence
of immune activating dietary antigens and bacterial components.
It is therefore no surprise to find that liver resident NK cells
are profoundly changed by residing in this microenvironment.
TGF-β is one of the chief mediators of the tolerogenic
hepatic environment and we have shown here that this
regulation extends to the phenotype and function of NK cells.
Through the suppression of Tbet, liver resident NK cells have
reduced pro-inflammatory potential but maintain their ability
to perform immunosurveillance in an organ prone to infection
and malignancy.
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